Salim Haffar, PCI Pharma Services CEO
March 14, 2023 02:02 PM EDT
Pharma
Manufacturing

PCI Phar­ma Ser­vices to in­vest $50M to boost pro­duc­tion at Illi­nois cam­pus

Tyler Patchen

News Reporter

Philadel­phia-based con­tract man­u­fac­tur­er PCI Phar­ma an­nounced on Tues­day plans to in­vest $50 mil­lion to build a new 200,000-square-foot man­u­fac­tur­ing fa­cil­i­ty at its cam­pus in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times